Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Consensus forecast Stories

2013-12-09 23:03:29

Market Publishers Ltd and FocusEconomics signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell FocusEconomics reports. London, UK (PRWEB) December 09, 2013 Market Publishers Ltd and FocusEconomics signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell FocusEconomics reports. Commenting on the agreement, Tanya...

2013-11-26 23:04:36

Reportbuyer.com just published a new market research report: Consensus Outlook: Multiple Sclerosis. London (PRWEB) November 26, 2013 Over the next five years, the global multiple sclerosis (MS) market is set to grow from $14.4 billion in 2012 to $18.3 billion in 2017. Primary drivers of this growth will be the entry of new pipeline therapies, satisfying the unmet needs of convenient administration and more efficacious therapy, and continued uptake of existing therapies. Therapy Trends...

2013-09-30 23:30:26

Reportbuyer.com just published a new market research report: Consensus Outlook: Prostate Cancer- Competition Intensifies in Race to the Top. London (PRWEB) September 30, 2013 Charting the Future Prostate Cancer Market Landscape The prostate cancer market has experienced substantial changes in the last five years with patent expiries of key compounds and approvals of new novel therapies. The launch of Zytiga (abiraterone acetate) and Medivation/Astellas’ Xtandi (enzalutamide) are set to...

2013-07-30 08:43:18

New app for iPad and iPad Mini eases 'anywhere, anytime' forecast collaboration BOSTON, July 30, 2013 /PRNewswire/ -- ToolsGroup, a leading provider of Powerfully Simple Solutions for Demand Analytics and Supply Chain Planning, has released a Demand Collaboration Hub (DCH) app for the iPad and iPad Mini (IOS 3.2 and higher). (Photo: http://photos.prnewswire.com/prnh/20130730/NE54932) iPad users can now contribute to and access current forecast information from anywhere, at any...

2013-04-09 12:24:03

LONDON and BOSTON, April 9, 2013 /PRNewswire/ -- EP Vantage Analyzes Accuracy of Analyst Sales Estimates for Blockbuster and Near-Blockbuster Launches Pharma industry observers widely expect Biogen Idec's new multiple sclerosis therapy Tecfidera to reach mega-blockbuster status. However, EP Vantage(R) [http://www.epvantage.com/default.aspx ], EvaluatePharma(R) [http://www.evaluatepharma.com ]'s award-winning editorial team cautions...